🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06842160
Starting soon Observational

Photoplethysmography (PPG) Algorithm with Smartwatch in Evaluation of Atrial Fibrillation Burden After Catheter Ablation

NCT06842160 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Anzhen Hospital
Phase
Observational
Started
2025-03-30
Last updated
2025-02-24

Condition(s) studied

Atrial Fibrillation (AF)

Investigational drug(s) / intervention(s)

intervention group

intervention group: A smart electrocardiogram watch based on the PPG algorithm for monitoring atrial fibrillation load after catheter ablation.

Study summary

The purpose of this study is to evaluate the effectiveness of a smart electrocardiogram watch based on the PPG algorithm in monitoring the atrial fibrillation burden of patients after catheter ablation.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Atrial fibrillation patients diagnosed by electrocardiogram 2. Received catheter ablation procedure 3. Willing to use long-range electrocardiogram monitoring equipment Exclusion Criteria: 1.Patients who are allergic to electronic devices or unable to wear watches

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Anzhen Hospital Beijing Beijing Municipality

More Beijing Anzhen Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06842160 on ClinicalTrials.gov ↗ ← All trials in China